Company Overview
Snapshot
Founded in July 2019, FullDNA operates with 1–10 employees. The company is currently in a Non Active status, having ceased operations in December 2024.
Business overview
FullDNA develops an AI-based, customizable genetics health prediction platform designed to enhance the capabilities of health professionals and institutions. The company utilizes artificial intelligence and complex algorithms to analyze DNA sequencing results, comparing them against its proprietary database to generate analysis and recommendation reports across various health, wellness, and sports domains. FullDNA operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Digital Medical Diagnostics, and serves healthcare providers and laboratories.
Company Intelligence Q&A
- What is FullDNA's primary business focus?
- FullDNA specializes in providing an AI-based, customizable genetics health prediction platform that supports health professionals and institutions by analyzing DNA sequencing results and offering health, wellness, and sports recommendations.
- When was FullDNA founded?
- FullDNA was founded in July 2019.
- What is the operational status of FullDNA?
- FullDNA is currently non-active, having ceased operations in December 2024.
- Who is a founder of FullDNA?
- Roberto Grobman is a founder of FullDNA.
- What technology does FullDNA primarily use?
- FullDNA primarily utilizes artificial intelligence and complex algorithms to analyze DNA sequencing data and generate health prediction reports.